Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma

Abstract

The higher plasma concentrations of inhaled corticosteroids in patients with a higher FEV(1)% predicted suggests that, for any given dose, these patients will be at greater risk of developing adverse systemic effects with long-term use.